In Vitro and in Vivo Properties of Bicyclic Lactam Inhibitors - A Novel Class of Low Molecular Weight Peptidomimetic Thrombin Inhibitors*

By Leblond L.   Grouix B.   Boudreau C.   Yang Q.   Siddiqui M.A.   Winocour P.D.  

Thrombosis Research, Vol. 100, Iss. 3, 2000-11 ,pp. : 195-209

Elsevier

Access to resources Recommend Favorite

Tissue factor regulation and cytokine expression in monocyte-endothelial cell co-cultures - Effects of a statin, an ACE-inhibitor and a low-molecular-weight heparin

By Lindmark E.   Siegbahn A.  

Thrombosis Research, Vol. 108, Iss. 1, 2002-10 ,pp. : 77-84

Elsevier

Access to resources Recommend Favorite

Signs of thrombin generation in pediatric cardiac catheterization with unfractionated heparin bolus or subcutaneous low molecular weight heparin for antithrombotic cover

By Roschitz B.   Beitzke A.   Gamillscheg A.   Sudi K.   Koestenberger M.   Leschnik B.   Muntean W.  

Thrombosis Research, Vol. 111, Iss. 6, 2003-01 ,pp. : 335-341

Elsevier

Access to resources Recommend Favorite

The Binding of Unfractionated Heparin and Low Molecular Weight Heparin to Thrombin-Activated Human Endothelial Cells - Identification by morphological and immunological criteria

By Young E.   Venner T.   Ribau J.   Shaughnessy S.   Hirsh J.   Podor T.J.  

Thrombosis Research, Vol. 96, Iss. 5, 1999-12 ,pp. : 373-381

Elsevier

Access to resources Recommend Favorite

Effect of Low Molecular Weight Heparins and Fondaparinux Upon Thrombin Generation Triggered by Human Pancreatic Cancer Cells BXPC3

By  

Current Vascular Pharmacology, Vol. 12, Iss. 6, 2014-11 ,pp. : 893-902

Bentham Science Publishers

Access to resources Recommend Favorite